Form 4: Twist Bioscience COO Sells Shares to Cover Tax Obligations
SEC Form 4
Patrick John Finn, President and COO of Twist Bioscience, sold 6,865 shares of common stock on October 2, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On October 2, 2024, Patrick John Finn, the President and COO of Twist Bioscience, sold 6,865 shares of the company's common stock.
- The sale was executed at a price of $43.211 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Finn directly owns 161,744 shares of Twist Bioscience.
- Some shares were acquired under the Issuer's Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (selling shares to cover taxes). It's neutral in sentiment as it doesn't convey positive or negative information about the company's performance or future prospects.
Industry Context
This is a routine Form 4 filing, indicating insider transactions. It is common for executives to sell shares to cover tax obligations related to vesting equity awards. The sale itself doesn't necessarily indicate a negative outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 10/02/2024 | Date of stock sale transaction. |
| 10/04/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.